Affymax Stock

Affymax Financial Leverage

The Financial Leverage (Equity Multiplier) of Affymax (AFFY) as of Aug 17, 2026 is -5.21.

Financial Leverage

-5.21

Last updated:

Financial Leverage (Equity Multiplier) of Affymax is 2026 -5.21 . Financial Leverage (Equity Multiplier) of Affymax was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

Financial Leverage (Equity Multiplier) of Affymax is -5.21 in 2026.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Affymax since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Affymax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Affymax

All Key Metrics — Affymax